MedPath

Entegard

Brand Name: Entegard

Generic Name: Entecavir

Active
Registration Number

DRP-6970

Dosage Form

Film-Coated Tablet

Issuance Date

May 31, 2022

Expiry Date

July 10, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mcg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiviral (Nucleoside and Nucleotide Reverse Transcriptase Inhibitor)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EntecavirActive
Monograph: Entecavir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform